Vitruvias Recalls One Lot of Thyroid Tablets Nationwide

Vitruvias Therapeutics has recalled one nationwide-distributed lot of Thyroid Tablets, USP 30 mg because testing found potential superpotency, which can expose patients to more thyroid hormone than intended.

More News